Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV single-arm study of Suhuang Zhike Capsule for cough variant asthma
ChiCTR1900025306Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of suhuang antitussive capsule in cough variant asthma (CVA), sponsored by China-Japan Friendship Hospital. Primary endpoints: 12-lead electrocardiogram, Chest X-ray examination and 2 more. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
suhuang antitussive capsule
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on ChiCTR1900025306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025306.